Result of Annual General Meeting | 21-Nov-2022 | 15:18 | RNS |
Licenses Vaccitech technology to advance Modi-2 | 07-Nov-2022 | 07:00 | RNS |
First patient dosed in expansion phase of ModiFY | 31-Oct-2022 | 07:00 | RNS |
Notice of AGM | 28-Oct-2022 | 15:00 | RNS |
Results for the year ended 30 April 2022 | 28-Oct-2022 | 07:00 | RNS |
Directorate Changes | 26-Oct-2022 | 07:00 | RNS |
Second Price Monitoring Extn | 25-Oct-2022 | 16:42 | RNS |
Price Monitoring Extension | 25-Oct-2022 | 16:37 | RNS |
Second Price Monitoring Extn | 25-Oct-2022 | 14:05 | RNS |
Price Monitoring Extension | 25-Oct-2022 | 14:00 | RNS |
Second Price Monitoring Extn | 25-Oct-2022 | 11:05 | RNS |
Price Monitoring Extension | 25-Oct-2022 | 11:00 | RNS |
Signs Commercial License Agreement with Genmab | 25-Oct-2022 | 07:00 | RNS |
Change of Nominated Adviser | 13-Oct-2022 | 07:00 | RNS |
Holding(s) in Company | 28-Sep-2022 | 12:31 | RNS |
Currency | UK Pounds |
Share Price | 11.31p |
Change Today | 0.19p |
% Change | 1.69 % |
52 Week High | 17.00 |
52 Week Low | 8.15 |
Volume | 178,831 |
Shares Issued | 927.98m |
Market Cap | £104.98m |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth | ![]() |
---|
Strong Buy | 0 |
Buy | 2 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 2 |
No dividends found |
Time | Volume / Share Price |
12:48 | 700 @ 11.22p |
12:08 | 1,266 @ 10.77p |
10:36 | 8,216 @ 10.77p |
10:05 | 16 @ 11.24p |
09:37 | 10,000 @ 11.25p |
CEO | Lindy Durrant |
CFO | Sath Nirmalananthan |
You are here: research